RP

Rhythm Pharmaceuticals

Organization

Heard in 2 episodes across 2 shows since Nov 2026

Rhythm Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing medicines for rare genetic diseases of obesity and related metabolic disorders.

Episodes

2
across 2 shows

First heard

Nov 2026

Expert statements

5
5 positive

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20260
Jul 20260
Aug 20260
Sep 20260
Oct 20260
Nov 20262

Email alert

Email me when Rhythm Pharmaceuticals comes up on a podcast

One email a week at most, with the new episodes that mention Rhythm Pharmaceuticals. Free, no account needed, unsubscribe in one click.

What experts have said about Rhythm Pharmaceuticals

5 statements · 5 positive

  1. Rhythm Pharmaceuticals treats a rare genetic form of obesity.

    “they treat a very rare form, a genetic form of obesity”

    Listen at 22:01

    Open the episode · Nasdaq Ekes Out Gain After Nvidia Earnings; Target, Rhythm Pharma, AMG In Focus
  2. Rhythm Pharmaceuticals’ drug received approval for an additional indication.

    “The drug just got an additional indication approved”

    Listen at 22:35

    Open the episode · Nasdaq Ekes Out Gain After Nvidia Earnings; Target, Rhythm Pharma, AMG In Focus
  3. Rhythm Pharmaceuticals has strong revenue growth and fund sponsorship.

    “Good revenue growth, good fund sponsorship.”

    Listen at 24:16

    Open the episode · Nasdaq Ekes Out Gain After Nvidia Earnings; Target, Rhythm Pharma, AMG In Focus

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

2 episodes featuring Rhythm Pharmaceuticals, newest first